About EyeYon Medical

Prof. Marcovich is Co-founder of EyeYon Medical, Head of Israeli cornea society, Deputy of the department of ophthalmology and senior ophthalmologist at the Kaplan Medical Centre. He is a specialist in corneal surgery at the University of Toronto, Canada. A former chairperson of the Israel Society of Cataract Surgeons, Dr. Marcovich conducts research at the Weizmann Institute of Science on corneal diseases. Dr. Marcovich has implemented the Endoart® in animals and led the Hyper-CL™ first clinical trial. He has presented his experience using both products at multiple meetings and conferences.

Mr. Nahum Ferera is an entrepreneur who specializes in leading medical device projects from idea to a successful product. Nahum founded EyeYon Medical together with Dr. Daphna and Dr. Marcovich 9 years ago and has served as CEO from the start. Nahum led the commercialisation of EyeYon’s first product – the Hyper-CL™ – from idea to CE approval and FDA clearance, and has extensive experience in c-level management, ophthalmic medical devices, business development, clinical trials, regulation and intellectual property. Prior to EyeYon Medical, Nahum led a project in non-invasive blood glucose monitoring, successfully passing clinical trials and resulting in a granted patent. His experience includes developing medical devices in the field of cardiac rate management based on MEMS technology.

Dr. Ofer Daphna is an inventor, entrepreneur and researcher, owner of several patents in the field of ophthalmology. He specialized in corneal and cataract surgery and is currently a senior Ophthalmologist at Assuta medical center, Tel-Aviv, Israel. Ofer is a high-volume cataract and corneal surgeon, conducting over 1000 operation per year (about 800 cataract and 300 corneal & refractive surgeries). He is the inventor of the EndoArt implant and the Hyper-CL™ therapeutic contact lens, as well as a co-founder of EyeYon Medical. Besides serving as Medical Director, he is also a Board Member. Ofer has performed about 150 animal operation pigs and rabbits, and will be responsible for training surgeons participating in the clinical trials planned in the project.

Charles has pursued a highly successful career in the pharma industry globally with over 25 years of experience, including senior positions in ophthalmology with Bayer, Allergan and Alcon. Most recently as VP and Global Head of Ophthalmology at Allergan.  While at Bayer, Charles was part of the global strategic marketing team responsible for launching Eylea® in the US and ROW markets.  Charles holds a Bachelor of Science degree from California State University.  Charles is nominated as EyeYon Medical’s Chief Commercial Officer to establish commercialization strategy for EyeYon’s overall products.

Mr. Dmitry Dubson has 16 years of experience in the medical device industry. He specialises in products development from concept to marketplace and led projects in the field of vascular implants, hernia meshes, drug delivery and wound care devices.

Dmitry has participated in a few EU projects, including development of a new therapy for glaucoma treatment, development of a biomimetic nano-polymer based gel for minimally invasive disc regeneration treatment, and development of personalized wound dressing based on nanofiber mats.

Dmitry is responsible for planning and executing the NPD pipeline from concept stage through production, defining product development milestones and the required budget. Dmitry is responsible for recruitment and management of R&D team and distribution of human resources. He coordinates tasks with other company departments, subcontractors and consultants, plans and executes V&V programs, monitors manufacturing and QC processes.

Dmitry is involved in annual budget preparation, costs forecasting, and short/long term production scheduling.

Dmitry holds a MSc in Electro-Optical Engineering from Ben-Gurion University.

Ethan is a certified public accountant with over 20 years of financial and business management experience in private and publicly traded medical device and healthcare organizations.  Experienced in new business development, growth management, strategy execution while leading financial activities at a global level.

Ethan leads EyeYon’s financial, legal and operational activities.  Ethan holds a B.A. in Accounting and Economics from Tel-Aviv University.

Dr. Malca Chen Zion serves as a Clinical and Regulatory Consultant for the medical industry. She has over two decades of experience in the fields of regulatory affairs, preclinical research and clinical trials of medical devices and biotechnology, with an extensive experience working with ophthalmology products. Malca holds a Ph.D. in Biology with highest distinction from Bar-Ilan University. Malca was a Lecturer for several years in Biotechnology program for M.Sc. students in Ort Broude College Israel.

As a Clinical and Regulatory Director she is leading our clinical trials worldwide and in charge of implementing regulatory requirements and submitting applications for marketing approval in various regions of the world. She is responsible for developing and implementing an optimal regulatory strategy, prepare and submit of regulatory binders, seek market authorizations, develop clinical study designs and write clinical study related documents and SOP’s.

Mrs. Limor Kuznits is an experienced VP of Clinical Affairs, with more than 11 years of background in various bio-medical companies.

In the last 3 years, she worked as the VP of Clinical Affairs for Momentis Surgical )previously known as Memic Innovative Surgery) which developed and commercialized a robotic-assisted surgical platform for transvaginal gynecologic procedures.

Limor will be in charge of the managing, implementation, and executing company clinical development plans.

Limor holds a BSc in Bio-Medical Engineering from Tel-Aviv University, Israel.

Mrs. Efrat Gilboa has 8 years -experience in the biomedical industry, specializing in hydrogels and controlled drug delivery systems. Prior to EyeYon Medical, Efrat was involved in projects for the development of an expanding battery for a drug-pump regulation, and a polymeric pill for the treatment of obesity. Efrat has also led a project for the controlled release of anti-inflammatory drugs from biodegradable coating, from its early stages and through pre-clinical trials. Efrat holds an M.Sc. in materials engineering from Tel-Aviv University.
Efrat, as a part of EyeYon’s R&D team, supports the development of the EndoArt corneal implant towards marketing. Her focus is on the materials’ aspect, research, testing and implementation of new manufacturing processes. Efrat is also responsible for the analysis of EndoArt’s clinical data from human trials.

Mrs. Oriah Mioduser is a bio-medical engineer, with expertise in medical devices, genomic analysis and project development and has substantial researcher skills.

Oriah is a member of our R&D team and contributes to the planning, managing, and the development of our projects. She is responsible for planning and performing in-vitro and in-vivo pre-clinical trials, coordinating tasks with subcontractors and external consultants, preparation of development files (TF, DHF, DMR) and literature reviews.

Prior to EyeYon, Oriah has participated in a few projects in the fields of drug eluting stenting systems and viral genomic analysis. Oriah holds a MSc in Bio-medical Engineering from Tel-Aviv University

Mrs. Anat Lemze has 15 years of experience in the optometry field, specializing in contact lenses, with a successful track record working in the Ophthalmology, Eye Institute Sheba Medical Center hospital, and health care industry. Anat has extensive knowledge in the Medical Devices field, Clinical operations, management, start-ups, distributors, and manufacturers. Anat is an experienced healthcare professional with a Bachelor of Science in Optometry from Bar-Ilan University and an MBA from the Open University.

As Senior Product Manager with years of experience in the contact lens industry, Anat manages and works with manufacturers and R&D specialists, specializing in products development, including EyeYon’s Hyper-CL™ Therapeutic Contact Lens. Anat’s experience working with cornea specialists enables her to provide and support ophthalmologists across the globe as they use EyeYon’s innovative products. In addition, management of the Hyper-CL™’s worldwide Clinical Trials activities as well as optimization of study documents, EDC system, studies enrollment, and providing medical staff support.

Mrs. Hagit Rudich Wilf has 17 years of experience in the medical device industry, in leading roles of project management, compliance and QA. Hagit has led medical device companies from various medical fields through successful CE certification and FDA approval (PMA) processes. She is responsible for managing the company’s Quality Management System (QMS), in compliance with regulatory requirements (ISO 13485, 21 CFR Part 820, MDD, MDR etc.) and for ensuring the awareness of regulatory and customer requirements throughout the organization. Hagit holds MSc in Biotechnology from the Hebrew University, Jerusalem, Israel.

Mali is a certified bookkeeper with over 8 years of office management, operation and bookkeeping experience with medical device companies in the commercial stage.

Han has extensive experience in clinical trials and registries of corneal medical devices with registration success at NMPA，who is well known in keratology and the clinical applications of corneal medical devices.

Han as Senior Clinical Manager in China will work with the Chinese regulatory authorities to support the registrations of EndoArt^®️ and Hyper-CL™️ towards NMPA approval. In addition, he will be responsible for the clinical studies and all commercial activities in China.

Nicholas joins EyeYon with over a decade of experience in the medical device industry, specialising in ophthalmic products and devices. He has successfully launched and sold various products for cataract, vitreoretinal, corneal, and oculoplastic surgeries. Nicholas’s expertise extends to working across Europe, managing clinical trials, distribution networks and fostering relationships with Key Opinion Leaders (KOLs). In his most recent role, Nicholas played a pivotal part in launching an innovative device for the treatment of dry eye disease in the UK.

With a background in start-up environments, he now brings his experience and drive to his position as Surgical Specialist, EU. Nicholas is committed to driving the commercial success of EyeYon’s devices across Europe, supporting surgeons in expanding their knowledge and utilization of EyeYon’s cutting-edge product portfolio.

Lauren joins EyeYon with over a decade of experience in the medical device industry, specialising in Ophthalmology and Orthopaedics through various commercial roles.  Her strategic insight and understanding of these fields have consistently driven innovation and growth for leading companies.

Lauren’s expertise spans Sales, Product Launches, Strategy development and building robust relationships with Key Opinion Leaders. Lauren joins us from Alcon and looks forward to bringing her wealth of knowledge and experience to the position of EyeYon Surgical Specialist, EU. She is dedicated to supporting our customers and driving the success and expansion of both EndoArt and Hyper CL across Europe.

Jake joins EyeYon medical from Alcon where he held the role of Surgical Glaucoma Specialist. He joined Alcon following their acquisition of Ivantis and proctored hundreds of Hydrus Microstent procedures as a certified instructor while collaborating with Global Glaucoma KOL’s to develop Alcon’s Glaucoma educational programme.

He has over 14 years’ experience in Ophthalmology having held a variety of both commercial and clinical roles. Jake developed his extensive knowledge of the Surgical Ophthalmic & Optical profession working with market leading presbyopia correcting IOL’s, in a regional management role at Lenstec Inc and spent many years developing community Ophthalmology models in the public healthcare system in the United Kingdom.

He now brings his commercial and technical expertise to the Eye-Yon medical team to help continue the expansion of EndoArt & Hyper CL.

Mrs. Tamar Shaked has 10 years of QA and clinical experience in various medical device companies. In the last 4 years, she worked as a CTM for Momentis Medical Surgery and was responsible for executing a clinical trial towards FDA and CE mark approval.

In her current role as CTM at EyeYon Medical, Tamar will be in charge of submitting and executing several clinical trials around the world.

Tamar holds an MSc in Microbiology from Haifa University, Israel.

Inbal has over 10 years of experience with project management and event planning and coordinating.

Inbal holds Bachelor of Business administration from Bernard M. Baruch College and MBA from Bar Ilan University.

Dr Kim serves as the current president of the American Society of Cataract and Refractive Surgery (ASCRS), serves on the Executive Committee of the Annual Program Committee of the AAO, and the Executive Committee and Board of Directors of the Cornea Society. He also sits on the Editorial Board for several peer-reviewed journals and trade publications, including Cornea, Journal of Cataract and Refractive Surgery, Ocular Surgery News, Eyeworld, Cataract & Refractive Surgery Today, Premier Surgeon, Review of Ophthalmology, and Advanced Ocular Care. Professor of Ophthalmology and Chief of the Cornea and External Division and Director of the Refractive Surgery Service at Duke University Eye Centre, his academic accomplishments include over 400 peer-reviewed journal articles, textbook chapters, and scientific abstracts. He is also editor and author of 5 well-respected textbooks on corneal diseases, corneal transplantation, and cataract surgery. Prof. Kim has used EyeYon’s Hyper-CL™ Therapeutic contact lens, he is integral to the EndoArt® Implant FDA submission process, and he will be one of the PIs of the local EndoArt® clinical trial.

Mr. Warner was a member of the Alcon Executive Leadership Team, the Global Franchise Head of Vision Care. Director, Global Pharmaceutical Marketing, and became Vice President of the same group, Area President, Canada, Latin America, and the Caribbean. Recently, Mr. Warner served as Region President for the U.S, leading more than 2,600 associates across three different business units – Pharmaceutical, Surgical, and Vision Care. Mr. Warner holds a Bachelor of Science degree in Chemistry from Pace University in New York, New York. He also holds a Master of Business Administration in Finance from Rutgers University in Newark, New Jersey. He has also completed the Advanced Management Program at the Harvard Business School.

Prof. Hong is Deputy Director of the department of ophthalmology at Peking University, Third Hospital, Professor, Chief Physician, doctoral tutor, director of the cornea ocular surface disease department, eye bank director, and committee member of the Chinese Ophthalmological Society Corneal Disease Group. She has published more than 100 papers in reputed journals. Prof. Hong is the PI of the first Hyper-CL™ Therapeutic contact lens trial in China, has implanted the EndoArt® implant in animals, and will lead the CFDA EndoArt® trial in China.

Dr. Güell is a founding partner of IMO and Coordinator of the Cornea, Cataract and Refractive Surgery Department of the IMO. He is ranked 16 in the 100 most influential people in ophthalmology, is Founding Director and past President of the European Society of Cornea and Ocular Surface Disease (EuCornea), and a member of the Editorial Board of influential periodicals such as Eurotimes Journal, Studium Ophthalmologicum, and Journal of Cataract and Refractive Surgery. He is also Coeditor of the Consultation Section at EyeWorld Magazine. He has logged 700 conferences/talks in national and international meetings and 250 articles in peer-reviewed journals as well as several book chapters. Prof. Güell used EyeYon’s Hyper-CL™ Therapeutic contact lens and he is one of the leading PIs of the FIH EndoArt® trial.

Currently practicing at the Wolfson Eye Institute, a large private ophthalmology group, Prof. Stulting is past president of ASCRS, former director of Emory University’s refractive surgery center, former editor-in-chief of Cornea, and a board member of the EBAA. Prof. Stulting has implemented the EndoArt® in animals and presented his experience at international conferences.

Deepinder K. Dhaliwal, MD, L.Ac, is a professor of ophthalmology at the University of Pittsburgh
School of Medicine, chief of Refractive Surgery and the co-director of the Cornea Service at the
UPMC Eye Center. She is vice chair of the department of ophthalmology for wellness and
communications. Dr. Dhaliwal also serves as the director of the UPMC Laser Vision Center, the
associate medical director of the Campbell Ophthalmic Microbiology Laboratory and the clinical
co-director of the Corneal Regeneration Laboratory at the University of Pittsburgh.
Dr. Dhaliwal earned her medical degree from Northwestern University in the Honors Program in
Medical Education where she was selected to be a member of the prestigious Alpha Omega
Alpha Honor Society. She completed her residency in ophthalmology at the University of
Pittsburgh Medical Center where she was selected as chief resident her final year. She then
pursued fellowship training in cornea and refractive surgery at the University of Utah. She
became a licensed acupuncturist in 2006 and founded the Center for Integrative Eye Care at the
University of Pittsburgh to research integrative treatments for eye disease.
Dr. Dhaliwal holds leadership positions in the Cornea Society, the International Society of
Refractive Surgery of the American Academy of Ophthalmology, and the Eye and Contact Lens
Association/CLAO. Dr. Dhaliwal is a recognized expert in her field and teaches corneal and
refractive surgical techniques to other ophthalmologists globally. In addition to teaching and
research activities, she has authored several book chapters, numerous journal articles, and
serves on the editorial board of several ophthalmology journals. In recognition of her clinical
and surgical skills, she has been selected as a “Top Doctor” by her peers every year since
2006. She was selected to be on the ​Power List 100 in The Ophthalmologist (“Top 100 most
influential people in the world of ophthalmology”), and received the ​International Society of
Refractive Surgery Casebeer Award for outstanding contribution to research and development
of refractive surgery.

Dr. Francis Mah received his medical degree from The University of Toledo College of Medicine and Life Sciences and Life Sciences and completed his residency at the University of Pittsburgh.

As an #ophthalmologist with more than 20 years experience and comprehensive expertise Dr. Francis Mah is specialized in advanced #corneal, #cataract and #refractive surgery. He holds leadership positions in various ophthalmology associations and societies. Next to teaching cataract surgery and #LASIK at various academy and society meetings worldwide, Dr. Mah is a popular speaker and valued educator who has shared his expertise in more than 200 lectures and clinical publications.

As an international expert on corneal infections, Dr. Mah is an advocate for using the latest techniques to ensure the best possible treatment for his patients.

Prof. Natalie Afshari, is Chief of Cornea and Refractive Surgery at the UC San Diego Shiley Eye Institute, USA and a proficient clinician, surgeon and research #cientist.

Prof. Afshari received her medical degree from Stanford University and completed her residency and fellowship training at Harvard University.
As a highly skilled cataract surgeon and recognized expert in corneal transplantation and refractive surgery, Prof. Afshari has been honored with multiple awards for her work. Her extensive list of accomplishments reach from several recognitions in “best doctors“ lists for her clinical practice, to honors for her numerous publications in medical and scientific journals and her commitment to teaching and training ophthalmologists. Prof. Afshari is also a member of several scientific committees and organizations.
The US Food and Drug Administration (FDA) has relied on her expertise in the safety and efficacy of various #ophthalmologic treatments.

Dr. Edward Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He attended the Loyola-Medical School in Chicago and trained in Ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa, and then a second fellowship in ocular immunology at the National Eye Institute. He has a national and international reputation for his knowledge and expertise in the field of cornea and external disease. Dr. Holland is the author of over 270 articles in peer review journals and has co-edited four editions of the textbook Cornea.